Skip to content
, EU FP7
Menu
    Primary NavigationPrimary Navigation
    • Home
    • Psilocybin Facts
      • History
        • Albert Hofmann
      • Ongoing/recently completed clinical trials
      • Latest scientific publications
      • Legals aspects concerning psilocybin
      • Molecular Structure & Chemical Details
    • Neuroscience
      • Psilocybin as a partial agonist of the 5-HT2A receptor
      • Neuronal interconnectivity
      • Neurochemical correlates of creativity
      • Psilocybin and neuroplasticity
      • Neuropolitics
      • Mycelia networks, adaptogens, and mental health
      • Neurochemistry
    • Psychology
      • Cross-modal synesthesia
      • Psilocybin and creativity
      • Psilocybin and ego-dissolution
      • Psilocybin and metacognition
      • Psilocybin and shamanism
      • Psilocybin and near-death anxiety
      • Psilocybin as a therapeutic adjunct for PTSD
      • Psilocybin and visual perception
      • Psilocybin as a catalyst of spiritual experiences
    • Psilocybin & Genetic Ageing
    • Philosophy of Mind
      • Psilocybin and Qualia
    • Misc
          • Imaginal cells
          • Full reference list HTML
          • From psychotomimetic to psychedelic
          • GoogleTrends analysis for Psilocybin (R-code)
          • Page overview
          • Media coverage of psilocybin
          • Hologenome theory of evolution
          • Documentaries
          • News
          • Podcasts
          • Psilocybin Research Blog
          • CogNovo
          • John M. Allegro
          • MindMap (dynamic information visualization)
          • Lectures
          • Homo consumens
          • Philosophy
          • Paul H. Hoch – Experimental lobotomies and psychopathology
          • Chemistry
          • Marie-Curie actions
          • CIA project MK Ultra
          • Gordon Wasson
          • A Review of the Clinical Effects of Psychotomimetic Agents
          • Mycophilia
          • EU FP7
          • Newsletter
          • www.psychedelic-lab.com
    • Varia
      • RSS

EU FP7

, EU FP7

The Framework Programmes for Research and Technological Development, also called Framework Programmes or abbreviated FP1 to FP7 with “FP8” being named “Horizon 2020“, are funding programmes created by the European Union/European Commission to support and foster research in the European Research Area (ERA).

More infos: https://ec.europa.eu/research/fp7/

3_fp7_benefittingsociety1


7th FRAMEWORK PROGRAMME
Download
psilocybin-research-logo-250px
, EU FP7

Psilocybin-Research.com

, EU FP7

Machine Learning Powered AI Translation

, EU FP7 English
, EU FP7 Afrikaans, EU FP7 العربية, EU FP7 বাংলা, EU FP7 Български, EU FP7 简体中文, EU FP7 Hrvatski, EU FP7 Čeština‎, EU FP7 Dansk, EU FP7 Nederlands, EU FP7 English, EU FP7 Filipino, EU FP7 Suomi, EU FP7 Français, EU FP7 Deutsch, EU FP7 Ελληνικά, EU FP7 ગુજરાતી, EU FP7 עִבְרִית, EU FP7 हिन्दी, EU FP7 Italiano, EU FP7 日本語, EU FP7 한국어, EU FP7 Latviešu valoda, EU FP7 മലയാളം, EU FP7 नेपाली, EU FP7 Norsk bokmål, EU FP7 فارسی, EU FP7 Polski, EU FP7 Português, EU FP7 Русский, EU FP7 Slovenščina, EU FP7 Español, EU FP7 Svenska, EU FP7 தமிழ், EU FP7 ไทย, EU FP7 Türkçe, EU FP7 اردو, EU FP7 Zulu

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Anything in here will be replaced on browsers that support the canvas element

  • Ego-dissolution
  • Psilocybin
  • Neurogenesis
  • Creativity
  • Ego-death
  • Psilocybin Patents
  • Psilocybin Innovations
  • Synaptoplasticity
  • Schizophrenia
  • Shamanism
  • Albert Hofmann
  • Hippocampus
  • 5-HT2A receptor
  • Neuroplasticity
  • Epidemiology
  • Suicidality
  • Mental Health
  • Openness to Experience
  • 5-Factor Model
  • Personality
  • Clinical Trials
  • Experimental Studies

Recent Posts

  • References 2022
  • Kary B. Mullis “Getting down with the molecules”
  • Psilocybin & Mental Health

Categories

Links

  • http://epigenetic-programming.de/
  • http://entheogen-science.de/
  • http://belief-bias.de/
  • http://self-reflection.de/
  • https://cognitive-liberty.online/
  • https://cognovo.net/
  • https://qbism.art/
  • https://psilocybin-research.com/

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Tags

5-Factor Model5-HT2A receptorAlbert HofmannCreativityEgo-deathEgo-dissolutionEpidemiologyHippocampusMental HealthNeurogenesisNeuroplasticityOpenness to ExperiencePersonalityPsilocybinPsilocybin InnovationsPsilocybin PatentsSchizophreniaShamanismSuicidalitySynaptoplasticity

Links
http://entheogen-science.de

Categories

  • Annecdotal evidence
  • Empirical studies
  • General
  • Media reports
  • Misc

Translation

, EU FP7 English
, EU FP7 Afrikaans, EU FP7 العربية, EU FP7 বাংলা, EU FP7 Български, EU FP7 简体中文, EU FP7 Hrvatski, EU FP7 Čeština‎, EU FP7 Dansk, EU FP7 Nederlands, EU FP7 English, EU FP7 Filipino, EU FP7 Suomi, EU FP7 Français, EU FP7 Deutsch, EU FP7 Ελληνικά, EU FP7 ગુજરાતી, EU FP7 עִבְרִית, EU FP7 हिन्दी, EU FP7 Italiano, EU FP7 日本語, EU FP7 한국어, EU FP7 Latviešu valoda, EU FP7 മലയാളം, EU FP7 नेपाली, EU FP7 Norsk bokmål, EU FP7 فارسی, EU FP7 Polski, EU FP7 Português, EU FP7 Русский, EU FP7 Slovenščina, EU FP7 Español, EU FP7 Svenska, EU FP7 தமிழ், EU FP7 ไทย, EU FP7 Türkçe, EU FP7 اردو, EU FP7 Zulu

Psilocybin Newsletter

Quotation

When we look within ourselves with psilocybin, we discover that we do not have to look outward toward the futile promise of life that circles distant stars in order to still our cosmic loneliness. We should look within; the paths of the heart lead to nearby universes full of life and affection for humanity.Terrence McKenna (*1946;†2000)

, EU FP7
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
(CC) 2016— by Dr. Christopher B. Germann (PhD, MSc, BSc, Marie Curie Alumnus)
https://neuropsy-webdesign.de
The project www.Psilocybin-Research.com was funded by the EU Marie Curie Initial Training Network FP7-PEOPLE-2013-ITN-604764
→ Primary goals of research and innovation policy as defined by the European Comission: Open Innovation, Open Science, Open to the World.
, EU FP7

Legal disclaimer: The interdisciplinary Marie Curie CogNovo program has been intentionally designed by the European Union and the University of Plymouth (United Kingdom) to discuss and disseminate a wide view on a diverse spectrum of topics including psychology, neuroscience, current affairs, basic science, humanities, and the arts, inter alia. Note that the views and opinions expressed on this website do not necessarily represent the opinions of any of the institutions mentioned on this website and belong exclusively to the copyright holder. The CogNovo program explicitly emphasises cognitive and social innovation, the generation of new ideas and perspectives, and the probing of boundaries, but see https://www.cognovo.eu/about/
Copyright © 2023 Psilocybin Research – OnePress theme by FameThemes